Filing Details
- Accession Number:
- 0001209191-10-017574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-17 13:00:00
- Reporting Period:
- 2010-03-15
- Filing Date:
- 2010-03-17
- Accepted Time:
- 2010-03-17 16:14:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187572 | Iii B John Henneman | 311 C Enterprise Drive Plainsboro NJ 08536 | Evp, Finance & Admin & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-03-15 | 2,565 | $42.33 | 89,748 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2010-03-16 | 16,200 | $35.52 | 105,948 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-16 | 16,200 | $43.08 | 89,748 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-03-16 | 16,200 | $0.00 | 16,200 | $35.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-11-15 | No | 4 | M | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $43.00 to $43.24.
- 25% of the shares vested on the first anniversary of the grant date of 11/15/2004 and the remaining 75% vest monthly thereafter over 36 months.
Billionaire Hedge Funds
